CJ Bioscience, Inc. (KOSDAQ:311690)
South Korea
· Delayed Price · Currency is KRW 9,300.00
+50.00 (0.54%)
At close: Dec 5, 2025
CJ Bioscience Revenue
CJ Bioscience had revenue of 737.90M KRW in the quarter ending September 30, 2025, a decrease of -0.85%. This brings the company's revenue in the last twelve months to 3.38B, down -14.90% year-over-year. In the year 2024, CJ Bioscience had annual revenue of 3.47B, down -37.82%.
Revenue (ttm)
3.38B
Revenue Growth
-14.90%
P/S Ratio
35.99
Revenue / Employee
n/a
Employees
n/a
Market Cap
121.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.47B | -2.11B | -37.82% |
| Dec 31, 2023 | 5.58B | 1.50B | 36.82% |
| Dec 31, 2022 | 4.07B | -288.37M | -6.61% |
| Dec 31, 2021 | 4.36B | -948.52M | -17.86% |
| Dec 31, 2020 | 5.31B | 528.32M | 11.05% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| KB Financial Group | 14.89T |
| HD Hyundai Heavy Industries | 16.39T |